当前位置:首页 - 行情中心 - 卫光生物(002880) - 财务分析 - 现金流量表

卫光生物

(002880)

  

流通市值:45.00亿  总市值:45.00亿
流通股本:2.27亿   总股本:2.27亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金641,164,391.88423,843,183.17170,052,177.141,221,649,170.7
  收到的税费返还302,204.19202,734.89202,734.896,499,372.9
  收到其他与经营活动有关的现金14,441,588.7514,114,972.45854,522.8852,564,822.61
  经营活动现金流入小计655,908,184.82438,160,890.51171,109,434.911,280,713,366.21
  购买商品、接受劳务支付的现金435,934,606.57281,665,182.87123,608,844.03573,845,362.75
  支付给职工以及为职工支付的现金194,043,452.1145,598,035.6398,927,538.31261,125,187.6
  支付的各项税费112,549,338.7687,037,735.545,479,561.32113,672,710.89
  支付其他与经营活动有关的现金48,929,468.3838,580,574.6520,684,518.5968,888,241.21
  经营活动现金流出小计791,456,865.81552,881,528.65288,700,462.251,017,531,502.45
  经营活动产生的现金流量净额-135,548,680.99-114,720,638.14-117,591,027.34263,181,863.76
二、投资活动产生的现金流量:
  收回投资收到的现金3,527,443.293,527,443.29--
  取得投资收益收到的现金1,997,706.86651,301.3768,424.6714,731,111.11
  处置固定资产、无形资产和其他长期资产收回的现金净额53,680.1653,680.16-37,844.42
  收到的其他与投资活动有关的现金240,000,000170,000,00060,000,000150,000,000
  投资活动现金流入小计245,578,830.31174,232,424.8260,068,424.67164,768,955.53
  购建固定资产、无形资产和其他长期资产支付的现金78,151,106.0958,072,073.2524,940,447.27169,689,898.91
  投资支付的现金34,900,00016,500,00016,500,000-
  支付其他与投资活动有关的现金200,000,000200,000,000200,000,000250,000,000
  投资活动现金流出小计313,051,106.09274,572,073.25241,440,447.27419,689,898.91
  投资活动产生的现金流量净额-67,472,275.78-100,339,648.43-181,372,022.6-254,920,943.38
三、筹资活动产生的现金流量:
  取得借款收到的现金--150,888,770.39421,314,597.72
  收到其他与筹资活动有关的现金450,618,682.53300,419,885.6-182,550,413.48
  筹资活动现金流入小计450,618,682.53300,419,885.6150,888,770.39603,865,011.2
  偿还债务支付的现金134,224,894.32123,364,535.32140,860,359450,501,362.2
  分配股利、利润或偿付利息支付的现金56,493,633.3652,938,135.73,927,276.6465,727,025.45
  支付其他与筹资活动有关的现金338,932,327.5196,204,885327,442.51,642,615
  筹资活动现金流出小计529,650,855.18372,507,556.02145,115,078.14517,871,002.65
  筹资活动产生的现金流量净额-79,032,172.65-72,087,670.425,773,692.2585,994,008.55
五、现金及现金等价物净增加额-282,053,129.42-287,147,956.99-293,189,357.6994,254,928.93
  加:期初现金及现金等价物余额368,985,365.99368,985,365.99368,985,365.99274,730,437.06
  期末现金及现金等价物余额86,932,236.5781,837,40975,796,008.3368,985,365.99
补充资料:
  净利润-44,628,464.44-245,791,094.36
  资产减值准备-2,104,615.67-25,044,059.98
  固定资产和投资性房地产折旧-69,991,901.84-145,028,262.85
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-69,991,901.84-145,028,262.85
  无形资产摊销-4,975,287.62-8,359,850.4
  长期待摊费用摊销-2,251,567.31-4,896,237.3
  固定资产报废损失--53,613.49-36,763.95
  公允价值变动损失----1,870,660.37
  财务费用-9,123,816.16-21,674,813.77
  投资损失--3,884,159.47--4,760,170.05
  递延所得税-3,910,674.76--13,502,726.48
  其中:递延所得税资产减少-3,899,944.09--12,749,314.87
    递延所得税负债增加-10,730.67--753,411.61
  存货的减少--126,949,289.68--92,874,389.64
  经营性应收项目的减少--3,101,344.18--330,438,589.46
  经营性应付项目的增加--118,335,009.47-239,446,813.57
  其他---15,234,931.86
  债务转为资本-0--
  现金的期末余额-81,837,409-368,985,365.99
  减:现金的期初余额-368,985,365.99-274,730,437.06
  现金及现金等价物的净增加额--287,147,956.99-94,254,928.93
公告日期2026-10-282026-08-142026-04-272026-04-27
审计意见(境内)标准无保留意见
TOP↑